tiprankstipranks
Trending News
More News >

David J. Wambeke Insider Profile

4 Followers
David J. Wambeke, CBO at Diamedica Therapeutics, holds 1.00M shares in NeuroOne Medical Technologies (Ticker: NMTC), holds 527.11K shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, David J. Wambeke Bought ― shares of NeuroOne Medical Technologies on Mar 03, 2026 for an estimated value of $670.00K.
tipranks
David J. Wambeke

David J. Wambeke
Diamedica Therapeutics (DMAC)
CBO

Ranked #20,861 out of 106,324 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+24.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
83.63%
16.37%
A breakdown of David J. Wambeke's holdings

Insider Roles

Diamedica Therapeutics
(DMAC)
CBO
NeuroOne Medical Technologies
(NMTC)
Chief Business Officer
Roles that David J. Wambeke holds in companies

Most Profitable Insider Trade

Stock:
Diamedica Therapeutics
(DMAC)
Rating:Informative Buy
Date:Nov 16, 2023 - Nov 16, 2024
Return:+68.40%
The most profitable trade made by David J. Wambeke

David J. Wambeke's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Diamedica Therapeutics
Nov 16, 2023
CBO
Informative Buy
49.20K
$3.84M
NeuroOne Medical Technologies
Mar 03, 2026
Chief Business Officer
Informative Buy
670.00K
$751.00K
List of latest transactions for each holding click on a transaction to see David J. Wambeke's performance on stock

David J. Wambeke insider profile FAQ

What is the percentage of profitable transactions made by David J. Wambeke?
The percentage of profitable transactions made by David J. Wambeke is 75%.
    What is the average return per transaction made by David J. Wambeke?
    The average return per transaction made by David J. Wambeke is 24.00%.
      What stocks does David J. Wambeke hold?
      David J. Wambeke holds: DMAC, NMTC stocks.
        What was David J. Wambeke’s latest transaction?
        David J. Wambeke latest transaction was an Informative Buy of $670.00K.
          What was David J. Wambeke's most profitable transaction?
          David J. Wambeke’s most profitable transaction was an Informative Buy of DMAC stock on November 16, 2023. The return on the trade was 68.40%.
            What is David J. Wambeke's role in Diamedica Therapeutics?
            David J. Wambeke's role in Diamedica Therapeutics is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.